Skip to main content

1 Result(s)

within Article Remove this filter Kenji Katsumata Remove this filter Oncology Remove this filter Pharmacology/Toxicology Remove this filter

and
Your search also matched 4 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement

Include preview-only content

  1. Article

    Open Access

    Safety analysis of two different regimens of uracil–tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial

    The JFMC33-0502 trial is a phase III clinical study designed to determine the most appropriate duration of postoperative adjuvant chemotherapy with uracil–tegafur (UFT) plus leucovorin in patients with stage ...

    Takashi Tsuchiya, Sotaro Sadahiro, Kazuaki Sasaki… in Cancer Chemotherapy and Pharmacology (2014)

    Download PDF (284 KB) View Article